Phase 2 PTSD Trial, Recruiting NCT05269459 Sponsor: University of Nebraska Condition: PTSD
Back to Ptsd

Phase 2 PTSD Trial, Recruiting

NCT05269459
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For all participants:

  • You are willing and able to give your consent to take part in the study
  • You are willing to follow all study procedures and are available for the full length of the study
  • You are between 21 and 65 years old
  • You are able to read and communicate in English
  • You use cannabis (marijuana/THC) on fewer than 3 days per week

For people with PTSD:

  • You have been diagnosed with PTSD according to current medical guidelines, with symptoms lasting at least 1 month
  • Your PTSD symptoms score at or above a certain level on a standard assessment scale at the time you join the study (confirm with trial site)
  • You have been on a stable mental health medication or therapy program for at least 4 weeks before joining

Who may not be able to join:

For all participants:

  • You are currently using any prescribed or over-the-counter CBD products (including the medication Epidiolex®)
  • You have had recent serious thoughts of suicide or made a suicide attempt within the past 6 months, as measured by a standard assessment tool
  • You have a thinking or memory problem that the study doctor believes would affect your ability to complete the study
  • You have had a moderate or serious problem with drug or alcohol use in the past 6 months (tobacco/nicotine use is allowed)
  • You have been using cannabis more than 3 days per week in the 4 weeks before joining
  • Your urine drug test comes back positive for any illegal substances other than cannabis
  • You are pregnant (confirmed by a blood test) or currently breastfeeding
  • You have a serious medical condition or are taking certain medications that the study doctor believes could make it unsafe for you to participate (confirm with trial site)
  • You have taken part in another research drug study or treatment trial within the past 3 months
  • You have a history of psychosis, active bipolar disorder, or borderline personality disorder diagnosed by a mental health professional
  • You have a history of an open head injury (a brain injury where the skull was broken)
  • You experienced a traumatic event within the past 30 days
  • You are currently on active military duty within the past 30 days
  • You have been admitted to a psychiatric hospital within the past 6 months
  • You have had a seizure in the past 6 months
  • You are currently taking HIV antiviral medications (note: PrEP, a medication to prevent HIV, is allowed)

For people without PTSD (control participants):

  • You have a previous diagnosis of PTSD
  • You are pregnant (by self-report) or currently breastfeeding

For participants who agree to have an MRI brain scan:

  • You have claustrophobia (fear of enclosed spaces), are pregnant, or have a condition the study doctor believes would make an MRI unsafe for you
  • You have any metal objects in or on your body, such as a pacemaker, metal implants, certain dental devices, cochlear implants, non-removable piercings, or metal fragments in your body
  • You have another medical condition the study doctor believes would interfere with the MRI scan (confirm with trial site)

Additional exclusions for people with PTSD:

  • Your only traumatic experience happened before the age of 18 and you have had no other traumas that could be connected to your PTSD
  • You have had an allergic reaction or serious side effects related to cannabis, CBD, or THC in the past
  • You are currently in a situation that is actively causing your PTSD
  • Your liver function blood test results are significantly above the normal range at the time of screening
  • If you are able to become pregnant, you are not willing to use at least one form of birth control throughout the study (acceptable methods include condoms, diaphragm, abstinence, or hormonal/implanted contraception such as the pill, injection, or IUD)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Matthew Rizzo, MD, University of Nebraska

Phone: 402-552-6239

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University of Nebraska
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Post-traumatic Stress Disorder Symptom Rating

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov